CME Beats on Cost Efficiency - Analyst Blog
July 28 2011 - 8:07AM
Zacks
CME Group Inc. (CME) reported its second
quarter earnings of $293.7 million or $4.38 per share, way ahead of
the Zacks Consensus Estimate of $4.17. The earnings also surpassed
the prior-year earnings of $270.7 million or $4.11 per share.
The improved result in the reported quarter was primarily
attributable to moderate volume growth and strong expense
management that also offset higher share count factor.
CME Group’s total revenue for the reported quarter slightly
increased 3% year over year to $838.3 million, also exceeding the
Zacks Consensus Estimate of $819 million. The increase was
primarily due to a surge in the average daily volumes across all
asset classes.
CME Group’s average daily volume was flat year over year at 13.5
million contracts in the reported quarter. However, total average
rate per contract increased 2% from the year-ago quarter to 80.7
cents.
Although volumes constituted mostly of lower-priced interest
rates ones, the relative stability in the rate per contract can be
attributed to favourable product and venue mix with growth coming
from energy and agricultural products in both exchange-traded and
CME ClearPort venues.
Besides, CME Group’s clearing and transaction fees marginally
increased 0.5% to $687.8 million, driven by higher interest rate
volume and revenue growth across agricultural commodities, energy
and metals product lines.
In addition, revenue earned from market data and information
services increased 5.8% year over year to $107.9 million and
revenue from access and communication fee increased 0.9% year
over year to $11.3 million while other revenues increased 89.7%
year over year to $31.3 million.
Nevertheless, total expenses also increased marginally by 1.7%
year over year to $303.8 million. As a result, operating margin
climbed to 64% from 63% in the year-ago quarter.
CME Group’s non-operating expense reduced 28.0% year over year
to $25.2 million, primarily owing to interest expense and borrowing
costs of $28.7 million and equity losses of $1.1 million, partially
offset by $4.6 million of investment income.
Financial Update
As of June 30, 2011, CME Group had $748.6 million of cash and
marketable securities, significantly down from $905.4 million as of
December 31, 2010. The company had $2.106 billion in long-term
debt, marginally higher from $2.105 billion at the end of December
31, 2010.
As of June 30, 2011, CME Group had total assets of $35.6 billion
(up from $35.0 billion as of December 31, 2010) while total
shareholders equity stood at $20.9 billion (up from $20.1 billion
as of December 31, 2010).
Stock Repurchase Update
On May 9, 2011, the board of CME Group had announced the
approval and authorization of a new share repurchase program worth
$750 million of common stock, expected to be held in the next 12
months. Following the sanction, the company bought back 220,000
shares for $65 million during the reported quarter.
Guidance
Concurrent with the earnings release, management provided a
revised expenses outlook for 2011. Accordingly, total operating
expense is estimated at $1.235 billion, down from $1.26 billion.
Besides, capital expenditure projection has been trimmed to $165
million from the prior guidance of $180 million. For the second
half of 2011, the effective tax rate is now expected to be
approximately 42.5%, down from 43.0%.
Dividend Update
On June 27, 2011, the board of CME group paid the second-quarter
dividend of $1.40 per share to shareholders of record as on June
20, 2011.
Peer Take
Yesterday, NASDAQ OMX Group Inc. (NDAQ)
reported its second quarter operating earnings per share of 62
cents, a couple higher than the Zacks Consensus Estimate of $0.60
but modestly ahead of $0.52 in the prior-year quarter. Meanwhile,
another prime peer, NYSE Euronext Inc. (NYX) is
scheduled to release its results before the market opens on August
2, 2011.
CME GROUP INC (CME): Free Stock Analysis Report
NASDAQ OMX GRP (NDAQ): Free Stock Analysis Report
NYSE EURONEXT (NYX): Free Stock Analysis Report
Zacks Investment Research
CME (NASDAQ:CME)
Historical Stock Chart
From Sep 2024 to Oct 2024
CME (NASDAQ:CME)
Historical Stock Chart
From Oct 2023 to Oct 2024